Results 131 to 140 of about 58,769 (219)

Karl Barth and the Historical Jesus [PDF]

, 2017
WEBER, JOSEPH C.
core  

Early Change in C-Reactive Protein and Venous Thromboembolism in Patients Treated With Immune Checkpoint Inhibitors. [PDF]

JACC CardioOncol
Moik F, Riedl JM, Barth D, Berton F, Fink M, Englisch C, Hoeller C, Fuereder T, Ay L, Pabinger I, Richtig E, John N, Kostmann SM, Jost PJ, Gerger A, Terbuch A, Preusser M, Ay C.   +17 more
europepmc   +1 more source

QSMxT: Robust masking and artifact reduction for quantitative susceptibility mapping. [PDF]

Magn Reson Med, 2022
Stewart AW, Robinson SD, O'Brien K, Jin J, Widhalm G, Hangel G, Walls A, Goodwin J, Eckstein K, Tourell M, Morgan C, Narayanan A, Barth M, Bollmann S.   +13 more
europepmc   +1 more source

KARL BARTH, Gespräche 1964-1968

Estudios Eclesiásticos, 2019
José J. Alemany
doaj  

One hundred years of excellence: the top one hundred authors of the Journal of Comparative Physiology A. [PDF]

J Comp Physiol A Neuroethol Sens Neural Behav Physiol
Zupanc GKH, Homberg U, Helfrich-Förster C, Warrant EJ, Simmons AM.   +4 more
europepmc   +1 more source

History of the German-language ENT journals. [PDF]

HNO, 2021
Stasche N, Bärmann M.
europepmc   +1 more source

[History of the German-language ENT journals. German version]. [PDF]

HNO, 2021
Stasche N, Bärmann M.
europepmc   +1 more source

Assessment of Retinopathy of Prematurity Regression and Reactivation Using an Artificial Intelligence-Based Vascular Severity Score.

JAMA Netw Open, 2023
Eilts SK, Pfeil JM, Poschkamp B, Krohne TU, Eter N, Barth T, Guthoff R, Lagrèze W, Grundel M, Bründer MC, Busch M, Kalpathy-Cramer J, Chiang MF, Chan RVP, Coyner AS, Ostmo S, Campbell JP, Stahl A, Comparing Alternative Ranibizumab Dosages for Safety and Efficacy in Retinopathy of Prematurity (CARE-ROP) Study Group.   +18 more
europepmc   +1 more source

R. Randal Bollinger, M.D., Ph.D., Master Surgeon. [PDF]

Front Transplant
Knechtle SJ, Kirk AD.
europepmc   +1 more source